Resources

The second WMC Newsletter includes a review of what 2023 might mean for the Italian wound care market, New German Nursing Qualifications, New Technologies is development and a snap shot of French wound care market stats,

Skin substitutes have been a part of the wound treatment armamentarium of medical practitioners for over 20 years, yet widespread adoption of these products in the US and other countries did not take off until just a few years ago.

Much has been written about the centrality of the patient’s own experience to the delivery of the care of their chronic wound. Their importance as stakeholder and actor in their own treatment is recognised but in many countries they remain without their own lobbying and self-help organisation.

The first Wound Market Consulting Newsletter of 2023 includes the extension of nurses decision making authority in Poland and Belgium, pharma’s interest in wound care and current clinical trials underway.

Andrew Adams of WMC and Mark Campbell (EX-NICE Associate/Programme Director, 2010-2019) discussed what MedTech companies hoping for NICE Guidance for the UK National Health Service (NHS) should and shouldn’t do.

Second in the Meet the Team series we introduce Dr Jirí Létal, Statistician.